Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Abiraterone PK/PD in CRPC
NCT01543776Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jan 2012
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Abiraterone Acetate Tablets (I) in castration-resistant prostate cancer (CRPC), sponsored by University of Chicago. Started Jan 2012; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT01543776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543776.